Some biotechs now use a "light" version of the GSK Template—focusing only on the Core Value Proposition and Strategic Imperatives—while larger companies maintain the full 50-slide deck.
In an industry where billions of dollars and millions of patient lives hang on launch execution, the GSK Template remains the gold standard because it answers the three fundamental questions of strategy: What is our unique value? For whom? And how will we deliver it consistently? gsk template
: As seen in Protocol Amendment 8 , templates are flexible enough to add new cohorts, such as those for adenoid cystic carcinoma, when pre-clinical data emerges. Evolution of Language Some biotechs now use a "light" version of
Current CGRP antagonists are injectable and expensive. Older oral drugs (topiramate, propranolol) have poor tolerability. Unmet need = effective, well-tolerated, affordable oral prevention. And how will we deliver it consistently